A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2011
11/17/2011	US20110281806 Peptides for preventing or treating liver damage
11/17/2011	US20110281805 Use of an ang-(1-7) receptor agonist in acute lung injury
11/17/2011	US20110281804 Peptidic and peptidomimetic compounds for regulating autophagy
11/17/2011	US20110281803 Sulfatase enzymes
11/17/2011	US20110281802 Composition for treatment and prevention of hair loss and premature graying of hair
11/17/2011	US20110281801 Prediction and prevention of preeclampsia
11/17/2011	US20110281800 Recombinant fusion proteins to growth hormone and serum albumin
11/17/2011	US20110281799 Vascular Endothelial Growth Factor D (VEGF-D) Antibodies and Vectors, and Methods of Uses
11/17/2011	US20110281798 Methods for Lowering Plasma Glucagon with Exendins and Exendin Agonist Analogs
11/17/2011	US20110281797 Site-specific monoconjugated insulinotropic glp-1 peptides
11/17/2011	US20110281796 Novel activin receptor and uses thereof
11/17/2011	US20110281795 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
11/17/2011	US20110281794 composition comprising nor-adrenaline and amphetamine for administering to a brain-dead, heart-beating potential organ donor
11/17/2011	US20110281793 Method For Reducing Cardiovascular Morbidity And Mortality In Prediabetic Patients And Patients With Type 2 Diabetes
11/17/2011	US20110281792 Binding-site modified lectins and uses thereof
11/17/2011	US20110281791 Crystalline insulin-conjugates
11/17/2011	US20110281790 Insulin with a stable basal release profile
11/17/2011	US20110281789 Ulbp antibodies
11/17/2011	US20110281788 Anti fungal therapy
11/17/2011	US20110281787 Pharmaceutical compositions comprising antisense oligonucleotides and methods of using same
11/17/2011	US20110281786 Stem cell expansion enhancing factor and method of use
11/17/2011	US20110281752 Beta-secretase enzyme compositions and methods
11/17/2011	US20110281292 Compositions and methods for identifying antigens which elicit an immune response
11/17/2011	US20110280978 Cosmetic use of botulinum toxin for the treatment of eyebrow and forehead ptosis, and unwanted eyebrow expression
11/17/2011	US20110280954 Compositions and methods for altering stool quality in an animal
11/17/2011	US20110280953 Compositions and methods for altering stool quality in an animal
11/17/2011	US20110280948 Compositions and methods for separating, characterizing and administering soluble selenoglycoproteins
11/17/2011	US20110280944 Fibrous microcapsules and methods of assembly and use thereof
11/17/2011	US20110280924 Biodegradable filler for restoration of alveolar bones
11/17/2011	US20110280922 Devices and methods for treating and/or preventing diseases
11/17/2011	US20110280921 Antibacterial hydrogel and use thereof in orthopedics
11/17/2011	US20110280919 Reinforced Absorbable Synthethic Matrix for Hemostatic Applications
11/17/2011	US20110280917 Resorbable thin membranes
11/17/2011	US20110280908 Multimeric protein toxins to target cells having multiple identifying characteristics
11/17/2011	US20110280903 Immunostimulatory combinations
11/17/2011	US20110280902 Compounds and methods for diagnosis and treatment of leishmaniasis
11/17/2011	US20110280897 Polypeptides and uses thereof
11/17/2011	US20110280893 Synthetic lipid a derivative
11/17/2011	US20110280889 High affinity t cell receptor and use thereof
11/17/2011	US20110280882 Leukolectins and uses thereof
11/17/2011	US20110280881 Novel anti-hsp90 monoclonal antibody
11/17/2011	US20110280879 Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies
11/17/2011	US20110280876 Mutated netrin - 4, fragments thereof and their use as medicines
11/17/2011	US20110280870 Hepatocyte growth factor receptor antagonists and uses thereof
11/17/2011	US20110280865 Ets-2 Biomarkers for Fibrotic Diseases and Uses Thereof
11/17/2011	US20110280864 Low Viscosity Highly Concentrated Suspensions
11/17/2011	US20110280861 Method for mir-125a in promoting hematopoietic stem cell self renewal and expansion
11/17/2011	US20110280859 Preventing and treating sepsis
11/17/2011	US20110280858 Treatment of wounds
11/17/2011	US20110280857 Advanced functional biocompatible foam used as a hemostatic agent for compressible and non-compressible acute wounds
11/17/2011	US20110280856 Treatment of alpha-galactosidase a deficiency
11/17/2011	US20110280855 Vitamin c compositions
11/17/2011	US20110280854 Compositions and methods for the treatment or the prevention of e. coli infections and for the eradication or reduction of e. coli surfaces
11/17/2011	US20110280853 Compositions and methods for treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfaces
11/17/2011	US20110280851 Compositions Comprising Cranberry Extract and Methods of Use Thereof
11/17/2011	US20110280842 Methods of reprogramming cells
11/17/2011	US20110280841 Electroprocessing in Drug Delivery and Cell Encapsulation
11/17/2011	US20110280838 Treatment of intervertebral disc degeneration using human umbilical cord tissue-derived cells
11/17/2011	US20110280834 Methods and compositions for cardiac tissue regeneration
11/17/2011	US20110280833 Peptides, derivatives and analogs thereof, and methods of using same
11/17/2011	US20110280832 Eotaxin-2 (ccl24) inhibitors in inflammatory, autoimmune, and cardiovascular disorders
11/17/2011	US20110280831 Combinations comprising methotrexate and dhodh inhibitors
11/17/2011	US20110280830 Albumin Fusion Proteins
11/17/2011	US20110280829 Low Molecular Weight Sulphated Polysaccharides as Candidates for Anti-Angiogenic Therapy
11/17/2011	US20110280828 Methods for treatment of microbial disorders
11/17/2011	US20110280827 Methods and compositions for treating hematological malignancies
11/17/2011	US20110280826 Y-shaped polyethylene glycol modified g-csf, the preparation and use thereof
11/17/2011	US20110280824 Furanone Copolymers
11/17/2011	US20110280813 Neuraminidase inhibitors and uses thereof
11/17/2011	US20110280809 Pdia4, target of cytopiloyne derivatives, for tumor diagnosis and treatment
11/17/2011	US20110280808 Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-Like Proteins
11/17/2011	US20110280800 Il-1 binding proteins
11/17/2011	US20110280799 Nanocells for diagnosis and treatment of diseases and disorders
11/17/2011	US20110280798 Cell Penetrating Peptides for Intracellular Delivery
11/17/2011	CA2833415A1 Gene therapy for diabetes with chitosan-delivered plasmid encoding glucagon-like peptide 1
11/17/2011	CA2799470A1 Humanized ttc and methods of use thereof
11/17/2011	CA2799197A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases
11/17/2011	CA2799169A1 Chlorotoxin variants, conjugates, and methods for their use
11/17/2011	CA2799095A1 Meganuclease variants cleaving a dna target sequence from the dystrophin gene and uses thereof
11/17/2011	CA2798957A1 Lactoferrin-based biomaterials for tissue regeneration and drug delivery
11/17/2011	CA2798713A1 Markers for acute kidney injury
11/17/2011	CA2795091A1 Process for the preparation of insulin-zinc complexes
11/17/2011	CA2792314A1 Modulation of scleraxis using a dominant negative scleraxis mutant with a basic dna-binding domain deletion
11/16/2011	EP2386856A2 Methods and means for treatment of osteoarthritis
11/16/2011	EP2386639A2 Modified pore-forming protein toxins and use thereof
11/16/2011	EP2386637A2 MicroRNA molecules
11/16/2011	EP2386636A2 ENA nucleic acid drugs modifying splicing in mRNA precursor
11/16/2011	EP2386630A1 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
11/16/2011	EP2386629A1 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
11/16/2011	EP2386574A2 Polypeptide variants with altered effector function
11/16/2011	EP2386572A1 Insulin derivative
11/16/2011	EP2386571A2 Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
11/16/2011	EP2386570A1 Recombinant melusin fusion protein as pharmacological agent in the treatment of heart pathologies and compositions thereof
11/16/2011	EP2386567A2 Mutants of cholesterol-dependent cytolysins and uses thereof
11/16/2011	EP2386566A2 Chi-conotoxin peptides (II)
11/16/2011	EP2386565A2 Compounds and methods to inhibit or augment an inflammatory response
11/16/2011	EP2386317A1 Methods for treating conditions associated with MASP-2 dependent complement activation
11/16/2011	EP2386316A1 Methods for treating conditions associated with MASP-2 dependent complement activation
11/16/2011	EP2386315A1 Methods for treating conditions associated with MASP-2 dependent complement activation
11/16/2011	EP2386312A2 Intrathecal and intratumoral superantigens to treat malignant disease

1 ... 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 ... 3163